Purchase Order HHSN269201700157P
Award Date 1/12/17
Potential Completion Date 3/31/17
Potential Value $21K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The NIH Clinical Center awarded a purchase order to Cardinal Health 414, LLC for $22,132.73 on November 5, 2018, with performance concluding November 4, 2019. Cardinal Health 414 supplies radiopharmaceuticals and medical isotopes to federal healthcare agencies. The order was issued on a firm fixed-price basis with no set-aside designation. Work is performed in Bethesda, Maryland. The company specializes in nuclear medicine and diagnostic imaging products including technetium-99m, iodine-123,...
- The National Institutes of Health Clinical Center awarded a purchase order to Cardinal Health 414, LLC for $6,016.81 on June 25, 2019. Work is performed in Bethesda, Maryland. The order covers radiopharmaceutical products on a firm fixed-price basis with an ultimate completion date of June 24, 2020. Cardinal Health 414 specializes in the manufacturing, testing, and distribution of radiopharmaceuticals and medical isotopes, providing products including technetium-99m, iodine-123, iodine-131,...
- The NIH Clinical Center issued a purchase order to Cardinal Health 414, LLC for radiopharmaceuticals valued at $18,784.13, awarded April 28, 2017, with completion by April 27, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Cardinal Health 414 manufactures and distributes radiopharmaceutical products including technetium-99m, iodine-131, indium-111, thallium-201, and fluorine-18 fluorodeoxyglucose to federal healthcare agencies, with...
- The National Institutes of Health Clinical Center awarded a purchase order to Cardinal Health 414, LLC for $17,846.51 on February 26, 2019, with completion by February 29, 2020. No set-aside was used. Work is performed at Bethesda, Maryland. The order procures radiopharmaceutical products on a firm fixed-price basis. Cardinal Health 414 specializes in manufacturing, testing, and distributing radiopharmaceuticals and medical isotopes to federal healthcare agencies, including technetium-99m,...
- The National Institutes of Health Clinical Center awarded a purchase order to Cardinal Health 414, LLC for $24,572.55 on March 14, 2018, with a final completion date of March 23, 2019. Performance occurs in Bethesda, Maryland. The order is priced firm fixed-price with no set-aside applied. Cardinal Health 414, a subsidiary of Cardinal Health, Inc., manufactures and distributes radiopharmaceuticals and medical isotopes for diagnostic imaging and nuclear medicine. The source does not specify the...
- The National Institutes of Health Clinical Center issued a purchase order to Cardinal Health 414, LLC for $24,382.25 on December 8, 2014, with an ultimate completion date of December 2, 2020. Work is performed in Bethesda, Maryland. The order procures radiopharmaceutical products for nuclear medicine and diagnostic imaging applications. Cardinal Health 414 is a subsidiary of Cardinal Health, Inc., specializing in manufacturing, testing, and distributing radiopharmaceuticals and medical...
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Cardinal Health 414, LLC valued at $15,108.57 on January 18, 2019. Work is performed in Bethesda, Maryland. The order is for radiopharmaceuticals and medical isotopes supplied on a firm fixed-price basis. Ultimate completion date is January 17, 2020.</p>
- This is a $22,733.47 firm fixed-price purchase order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the National Institutes of Health (NIH) Clinical Center. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH research centers. Cardinal Health 414 also provides...
- This is a $22,093.85 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 provides both scheduled...
- This federal contract award, valued at $3,510.00, was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at the NIH Clinical Center. This is a...